Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

All GLG News Analyses Filed Under: Business of Medicine

Articles with lock require a GLG News subscription
Posted April 21, 2008
Debiopharm and Airmid Sign Option and License Agreement
Analysis of: Debiopharm and Airmid Sign Option and License Agreement | www.pipelinereview.com
Author: GLG Member Program Contributor
Potassium channels are ‘pores’ in the membrane surrounding cells that modulate the flow of potassium (also called ‘K+’). This modulation is one of the basic interactions of life in all living cells. The scientific community is still learning the ramification of the modulation of these channels.
Richard Baland Posted April 21, 2008
What can Hospitals do about their Spending and Borrowing in 2008?
Analysis of: University Hospitals in Cleveland makes aggressive refinancing move | blog.cleveland.com
Author: Richard Baland, Chief Financial Officer & Chief Compliance Officer Richardson Medical Center
Increasing interest rates and debt service, a Decrease in available cash, a Migration to more fixed rate borrowing and appeals to state governments for assistance, a delay in physical plant additions/upgrades
Posted April 21, 2008
Reports: Data on Vioxx was misused
Analysis of: Reports: Data on Vioxx was misused | www.usatoday.com
Author: GLG Member Program Contributor
The more we learn the more likely it is that we cannot trust big pharma or the scientists who get grants to do research for them. The FDA really needs to do a better job to protect the public!
Posted April 21, 2008
Feds Try to Cut the Costs of Hospital Errors
Analysis of: Feds Try to Cut the Costs of Hospital Errors | www.forbes.com
Author: GLG Member Program Contributor
The Medicare Program stunned much of the hospital world last year when they stated that beginning in October, 2008 (Federal Fiscal Year 2009) it would no longer pay for the costs Medicare patients generated for their treatment of eight conditions not present on admission which were likely the result...
Posted April 21, 2008
Reports: Data on Vioxx was misused
Analysis of: Reports: Data on Vioxx was misused | www.usatoday.com
Author: GLG Member Program Contributor
The authors of this study obtained the data while representing plaintiffs and their lawyers.Surely they come from a biased viewpoint and perhaps more biased than groups of researchers who have performed a study may not have written all of a final manuscript but had the chance to review it.      ...
Eric Gruff Posted April 21, 2008
Tainted Heparin Will Mean More Scrutiny of Drug Manufacturers
Analysis of: UPDATE: FDA Head Sees Economic Fraud Behind Tainted Heparin | www.reuters.com
Author: Eric Gruff, Principal E4 Consulting
Regardless of the reason (greed, carelessness, incompetence, etc.) that Chinese heparin became tainted, the end result will be increased scrutiny on imported raw materials and other ingredients, not only from China, but from all 3rd World suppliers. How the FDA and other regulatory agencies actually...
Posted April 15, 2008
Where The Jobs Aren’t: Research & Development
Analysis of: Where The Jobs Aren’t: Research & Development | www.pharmalot.com
Author: GLG Member Program Contributor
To paraphrase, rumors of big pharma's demise are vastly exaggerated.
Gary Barker Posted April 15, 2008
Novartis grabs a winner
Analysis of: Novartis to buy Nestle's Alcon stakes for $39 billion | www.wtnzfox43.com
Author: Gary Barker, Partner/Owner Eye Associates Of Winter Park
The purchase of a controlling interest in Alcon by Novartis is a brilliant move by Novartis.  To bring the leading contact lens disinfectant together with Ciba's contact lenses is a wonderful marketing opportunity for Ciba.
Posted April 14, 2008
FDA to take key step in stem cell research
Analysis of: FDA to take key step in stem cell research | money.cnn.com
Author: GLG Member Program Contributor
Stem cells have a great potential for a wide range of medical treatments.  Laying out the direction to allow for clinical studies is an important step. Cancer Stem cell research is a new area where modulation of stem cell activity may prevent metastatic events.  The FDA's concern for embryonic...
Posted April 14, 2008
U.S. Reps give boost to physician-owned hospitals
Analysis of: U.S. Reps give boost to physician-owned hospitals | www.fiercehealthcare.com
Author: GLG Member Program Contributor
2 Texas U.S. Reps think that physcian owned hospitals are OK?
Previous Page : 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Next171 to 180 of 573

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-08-30T01:45:15.453